| X24-09-YM815 |
NBMPR, Purity ≥98%
|
|
| X24-09-YM816 |
FP Receptor inhibitor, Treprostinil, Purity ≥98%
|
|
| X24-09-YM817 |
SCH 54292, Purity ≥98%
|
|
| X24-09-YM818 |
PF-06687859, Purity ≥98%
|
|
| X24-09-YM819 |
Beloranib, Purity ≥98%
|
|
| X24-09-YM820 |
Linerixibat, Purity ≥98%
|
|
| X24-09-YM821 |
LHW090-A7, Purity ≥98%
|
|
| X24-09-YM822 |
TNP-470, Purity ≥98%
|
|
| X24-09-YM824 |
NB-598, Purity ≥98%
|
|
| X24-09-YM825 |
Topiroxostat, Purity ≥98%
|
|
| X24-09-YM826 |
PDHK1 inhibitor, AZD 7545, Purity ≥98%
|
|
| X24-09-YM827 |
Ro 48-8071, Purity ≥98%
|
|
| X24-09-YM829 |
Phosphoramidon disodium salt, Purity ≥98%
|
|
| X24-09-YM831 |
CAY10650, Purity ≥98%
|
|
| X24-09-YM832 |
PCI-27483, Purity ≥98%
|
|
| X24-09-YM834 |
T-5224, Purity ≥98%
|
|
| X24-09-YM835 |
BMX-IN-1, Purity ≥98%
|
|
| X24-09-YM836 |
Cot inhibitor-2, Purity ≥98%
|
|
| X24-09-YM837 |
EMD638683, Purity ≥98%
|
|
| X24-09-YM838 |
MB05032, Purity ≥98%
|
|
| X24-09-YM839 |
N3PT, Purity ≥98%
|
|
| X24-09-YM840 |
NB-598 hydrochloride, Purity ≥98%
|
|
| X24-09-YM841 |
NB-598 maleate, Purity ≥98%
|
|
| X24-09-YM842 |
ST 2825, Purity ≥98%
|
|
| X24-09-YM843 |
iMAC2, Purity ≥98%
|
|
| X24-09-YM844 |
Cyclosporin H, Purity ≥98%
|
|
| X24-09-YM845 |
K-7174, Purity ≥98%
|
|
| X24-09-YM846 |
K-7174 2HCl, Purity ≥98%
|
|
| X24-09-YM847 |
KRX-0402, Purity ≥98%
|
|
| X24-09-YM848 |
CBFβ-SMMHC inhibitor, AI-10-49, Purity ≥98%
|
|
| X24-09-YM849 |
AZ7371, Purity ≥98%
|
|
| X24-09-YM850 |
ML-281, Purity ≥98%
|
|
| X24-09-YM851 |
Lesinurad sodium, Purity ≥98%
|
|
| X24-09-YM852 |
Sardomozide HCl, Purity ≥98%
|
|
| X24-09-YM853 |
WWL70, Purity ≥98%
|
|
| X24-09-YM854 |
Y-29794 Tosylate, Purity ≥98%
|
|
| X24-09-YM855 |
Y-29794 oxalate, Purity ≥98%
|
|
| X24-09-YM856 |
Decanoyl-RVKR-CMK, Purity ≥98%
|
|
| X24-09-YM857 |
Butabindide oxalate, Purity ≥98%
|
|
| X24-09-YM858 |
CGS 35066, Purity ≥98%
|
|
